Log In
Print
BCIQ
Print
Print this Print this
 

COG112

  Manage Alerts
Collapse Summary General Information
Company Cognosci Inc.
DescriptionApolipoprotein E mimetic peptide
Molecular Target Nuclear factor of kappa light polypeptide gene enhancer in B cells 1 (NF-kB) (NFKB1) (p105) (p50)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat Multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today